(Q74604726)
Statements
Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function (English)
S K Swan
J F Baker
R Free
R M Tucker
B Barron
R Barr
S Seltzer
G S Gazelle
K R Maravilla
W Barr
G R Stevens
L J Lambrecht
1 February 1999